Holen Sie sich die Stockscreener-App
3.58
5.03%
0.20
Schlusskurs vom Vortag:
$3.38
Offen:
$3.42
24-Stunden-Volumen:
2.22M
Relative Volume:
2.10
Marktkapitalisierung:
$279.87M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-144.32M
KGV:
-1.6422
EPS:
-2.18
Netto-Cashflow:
$-105.21M
1W Leistung:
+17.55%
1M Leistung:
+14.52%
6M Leistung:
-44.27%
1J Leistung:
-57.54%
1-Tages-Spanne:
$3.40
$3.70
1-Wochen-Bereich:
$2.94
$3.70
52-Wochen-Spanne:
$2.49
$9.63
Compass Pathways Plc Adr Stock (CMPS) Company Profile
Firmenname
Compass Pathways Plc Adr
Sektor
Branche
Telefon
1-716-676-6461
Adresse
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Vergleichen Sie CMPS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
3.57 | 279.87M | 0 | -144.32M | -105.21M | -2.18 |
|
HCA
Hca Healthcare Inc
|
322.81 | 82.61B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.00 | 14.48B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
133.82 | 11.79B | 12.67B | 827.68M | 1.42B | 9.27 |
|
UHS
Universal Health Services Inc
|
160.83 | 11.44B | 15.42B | 1.03B | 956.84M | 15.02 |
|
THC
Tenet Healthcare Corp
|
113.83 | 11.20B | 20.97B | 3.13B | 2.39B | 31.21 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-27 | Eingeleitet | Stifel | Buy |
| 2024-07-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2022-11-21 | Fortgesetzt | Berenberg | Buy |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2021-10-29 | Eingeleitet | Oppenheimer | Outperform |
| 2021-07-13 | Eingeleitet | Citigroup | Buy |
| 2021-06-28 | Eingeleitet | Maxim Group | Buy |
| 2021-05-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-01 | Eingeleitet | ROTH Capital | Buy |
| 2020-10-14 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-10-13 | Eingeleitet | Berenberg | Buy |
| 2020-10-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-10-13 | Eingeleitet | Cowen | Outperform |
| 2020-10-13 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Compass Pathways Plc Adr Aktie (CMPS) Neueste Nachrichten
CMPS’s Market Whiplash: -10.58% YTD Decline, 14.00% Rise in 30 Days - investchronicle.com
Compass Pathways appoints new US accounting firm By Investing.com - Investing.com South Africa
Compass Pathways appoints new US accounting firm - Investing.com
Compass Pathways Plc ADR (NASDAQ: CMPS) Could Slash -707.02% Soon - stocksregister.com
An In-Depth Look at Larimar Therapeutics Inc Inc. (LRMR) Price Performance During Market Crashes - investchronicle.com
Compass Pathways stock hits 52-week low at $2.87 By Investing.com - Investing.com South Africa
Compass Pathways stock hits 52-week low at $2.87 - Investing.com
Cantor Fitzgerald maintains Overweight on Compass Pathways stock By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains Overweight on Compass Pathways stock - Investing.com India
Compass Pathways stock hits 52-week low at $3.15 By Investing.com - Investing.com South Africa
Compass Pathways stock hits 52-week low at $3.15 - Investing.com India
What Do Wall Street Analysts Think About Compass Pathways Plc ADR (NASDAQ: CMPS) Stock? - Stocks Register
Pinnacle Financial Partners Inc (PNFP) may enjoy gains as insiders got busy in the recent days - Knox Daily
Compass Pathways shares surge on cash runway expectations - Investing.com
Compass Pathways shares surge on cash runway expectations By Investing.com - Investing.com UK
Earnings call transcript: Compass Pathways Q4 2024 sees stock rise amid stable EPS - Investing.com
Comprehensive Market Analysis of Latest Published Different Types of Depression Reports | DelveInsight - GlobeNewswire Inc.
Market Watch Highlights: Himax Technologies ADR (HIMX) Ends on an Downturn Note at 9.53 - The Dwinnex
Li-Cycle Holdings Corp (LICY)’s Day in Review: Closing at 0.85, Down by -2.72 - The Dwinnex
Now Is The Time To Build A Position In Compass Pathways Plc ADR (NASDAQ:CMPS) - Marketing Sentinel
A better buy-in window may exist right now for Compass Pathways Plc ADR (CMPS) - SETE News
Compass Pathways Plc ADR (CMPS) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Financial Analysis: Compass Pathways Plc ADR (CMPS)’s Ratios Unveil Key Insights - The Dwinnex
Metric Deep Dive: Understanding Envista Holdings Corp (NVST) Through its Ratios - The Dwinnex
Compass Pathways Plc ADR (CMPS) Stock: A Closer Look at the Analyst Ratings - The News Heater
Analysts review Compass Pathways Plc ADR’s rating - Knox Daily
Can you still get a good price for P3 Health Partners Inc (PIII) Shares at this point? - US Post News
How did Adaptive Biotechnologies Corp (ADPT) fare last session? - US Post News
A stock that deserves closer examination: Compass Pathways Plc ADR (CMPS) - US Post News
Compass Pathways Plc ADR (NASDAQ:CMPS) Could Really Rise To 23 In 12 Months, According To Analysts. - Marketing Sentinel
Market Highlights: Rocket Lab USA Inc (RKLB) Ends on a High Note at 31.57 - The Dwinnex
Indonesia Energy Corp Ltd (INDO) Is On The Launchpad, Waiting For Long-Term Buyers. - Stocks Register
Compass Pathways stock hits 52-week low at $3.57 - Investing.com
Origin Materials Inc (ORGN): Be Patient, You Will Learn - Stocks Register
At $0.81 Price, AIX Inc. ADR (AIFU) Is Sitting And Waiting - Stocks Register
Compass Pathways stock hits 52-week low at $3.85 - Investing.com
Compass Pathways stock hits 52-week low at $3.99 - Investing.com
Compass Pathways' SWOT analysis: psilocybin stock faces trials and trillion-dollar potential - Investing.com
Compass Pathways stock touches 52-week low at $4.01 - Investing.com
Vaccine Stocks Slide, Psychedelic Stocks Surge After RFK Jr. HHS Nomination - Barchart
Volatility Of Blend Labs Inc (BLND) Reaches 5.82%: Make Sure To Keep Your Seat Tight! - Stocks Register
KULR Technology Group Inc (KULR) Analyst Thoughts: How High Can It Go? - Stocks Register
Compass stock still a Buy, but target halved amid focus on TRD program - Investing.com UK
Earnings call: COMPASS Pathways reports Q3 results and trial updates - Investing.com
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript - Barchart
Compass Pathways stock hits 52-week low at $4.25 - Investing.com
Compass Pathways shareholder Goldsmith sells shares in private deal - Investing.com
Compass Pathways investor Goldsmith sells shares in private deal By Investing.com - Investing.com
Compass Pathways shareholder Ekaterina Malievskaia sells shares in private transaction - Investing.com
Market Recap Check: Compass Pathways Plc ADR (CMPS)’s Positive Finish at 6.12, Up/Down 1.66 - The Dwinnex
Trading Day Triumph: Compass Pathways Plc ADR (CMPS) Ends at 6.30, a -7.49 Surge/Plunge - The Dwinnex
Finanzdaten der Compass Pathways Plc Adr-Aktie (CMPS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Compass Pathways Plc Adr-Aktie (CMPS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Malievskaia Ekaterina | 10% Owner |
May 21 '24 |
Sale |
7.91 |
8,900 |
70,379 |
3,931,687 |
| Malievskaia Ekaterina | 10% Owner |
May 21 '24 |
Sale |
7.91 |
8,900 |
70,379 |
3,929,413 |
| Malievskaia Ekaterina | 10% Owner |
May 20 '24 |
Sale |
7.89 |
6,704 |
52,908 |
3,938,313 |
| Malievskaia Ekaterina | 10% Owner |
May 20 '24 |
Sale |
7.89 |
6,703 |
52,900 |
3,940,587 |
| Goldsmith George Jay | 10% Owner |
May 21 '24 |
Sale |
7.91 |
8,900 |
70,379 |
3,929,413 |
| Goldsmith George Jay | 10% Owner |
May 21 '24 |
Sale |
7.91 |
8,900 |
70,379 |
3,931,687 |
| Goldsmith George Jay | 10% Owner |
May 20 '24 |
Sale |
7.89 |
6,704 |
52,908 |
3,938,313 |
| Goldsmith George Jay | 10% Owner |
May 20 '24 |
Sale |
7.89 |
6,703 |
52,900 |
3,940,587 |
| Goldsmith George Jay | 10% Owner |
May 03 '24 |
Sale |
8.82 |
18,762 |
165,456 |
3,947,290 |
| Goldsmith George Jay | 10% Owner |
May 03 '24 |
Sale |
8.82 |
18,761 |
165,448 |
3,945,017 |
0.27%
5.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):